Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 22 minutes ago
Back to Filings
FORM SC 13D/A
AI

Ownership Report - September 18, 2023

Filed September 18, 2023
·
0001193125-23-236978

Peter Beck's trust sells 3.6M RKLB shares at $5.62, retains 10.5% stake.

Brief

This SC 13D/A amendment discloses Equatorial Trust, linked to Rocket Lab CEO Peter Beck, sold 3,600,000 common shares on September 11, 2023, via block trade with Goldman Sachs at $5.62 per share. Post-sale beneficial ownership is 50,951,250 shares (10.5%). Beck orally agreed not to sell additional shares in 2023.

Detailed Brief

Amendment No. 1 to the Schedule 13D, originally filed September 7, 2021, updates ownership by Peter Beck, Equatorial Trust (New Zealand trust), its trustee Peek Street Equatorial Trustee Limited, and directors Kerryn Beck and Warren Butler. The Trust sold 3,600,000 shares (~$20.2M) in a block trade on September 11, 2023, reducing holdings to 50,951,250 shares (10.5% of 483M outstanding as of August 3, 2023). Peter Beck, Rocket Lab's founder/CEO, shares voting/dispositive power as one of three trustee directors. No other transactions in past 60 days. An oral agreement with Goldman Sachs restricts further Trust/Beck sales of RKLB shares in 2023, signaling short-term stability in insider position.

Key Telemetry

  • Equatorial Trust sold 3,600,000 shares on 9/11/2023 at $5.62/share (~$20.2M) to Goldman Sachs.
  • Post-sale: 50,951,250 shares beneficially owned (10.5% of class).
  • Peter Beck (CEO) and two others share control via trustee role.
  • Oral commitment: No additional sales by Beck/Trust in 2023.
  • Original 13D from 2021; this amends Items 4,5,6.

Risk Signals

Insider Selling
CEO Peter Beck's trust disclosed large sale of 3.6M shares (~$20M) via SC 13D/A, representing position change.

Impact Vector

Investors should note CEO-affiliated insider selling of ~$20M worth of shares, potentially signaling profit-taking amid stock volatility, but the remaining 10.5% stake (~51M shares) demonstrates strong alignment with shareholders. The 2023 no-sell pledge to Goldman Sachs reduces near-term dilution/pressure risk from this holder. Strategically neutral for Rocket Lab's launch business; monitor Q3 results, future 13D/G updates, or secondary offerings for selling trends.

Search
Search across missions, customers, news, and SEC filings